These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17132715)

  • 1. Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia.
    Deng R; Balthasar JP
    Blood; 2007 Mar; 109(6):2470-6. PubMed ID: 17132715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.
    Crow AR; Yu H; Han D; Lazarus AH
    PLoS One; 2013; 8(8):e71882. PubMed ID: 23940791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
    Song S; Crow AR; Freedman J; Lazarus AH
    Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic effects of high-dose monoclonal antibody therapy in a rat model of immune thrombocytopenia.
    Jin F; Tayab ZR; Balthasar JP
    AAPS J; 2006 Jan; 7(4):E895-902. PubMed ID: 16594642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic/pharmacodynamic modeling of IVIG effects in a murine model of immune thrombocytopenia.
    Deng R; Balthasar JP
    J Pharm Sci; 2007 Jun; 96(6):1625-37. PubMed ID: 17238194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia.
    Hansen RJ; Balthasar JP
    Blood; 2002 Sep; 100(6):2087-93. PubMed ID: 12200371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.
    Crow AR; Amash A; Lazarus AH
    Transfusion; 2015 Jun; 55(6 Pt 2):1492-500. PubMed ID: 25496771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice.
    Tremblay T; Aubin E; Lemieux R; Bazin R
    Br J Haematol; 2007 Oct; 139(2):297-302. PubMed ID: 17897306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia.
    Deng R; Balthasar JP
    Int J Pharm; 2005 Nov; 304(1-2):51-62. PubMed ID: 16171959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity.
    Crow AR; Song S; Semple JW; Freedman J; Lazarus AH
    Br J Haematol; 2001 Dec; 115(3):679-86. PubMed ID: 11736954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies.
    Webster ML; Sayeh E; Crow M; Chen P; Nieswandt B; Freedman J; Ni H
    Blood; 2006 Aug; 108(3):943-6. PubMed ID: 16861348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of cytokine modulation following therapeutic infusion of intravenous immunoglobulin or anti-red blood cell antibodies in a mouse model of immune thrombocytopenic purpura.
    Aubin E; Lemieux R; Bazin R
    Br J Haematol; 2007 Mar; 136(6):837-43. PubMed ID: 17341270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody specific for the glycophorin A complex mediates intravenous immune globulin-resistant anemia in a murine model.
    Chen X; Ghaffar H; Jen CC; Lazarus AH
    Transfusion; 2014 Mar; 54(3):655-64. PubMed ID: 23782137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects.
    Yu X; Menard M; Seabright G; Crispin M; Lazarus AH
    Transfusion; 2015 Jun; 55(6 Pt 2):1501-11. PubMed ID: 25752470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.
    Song S; Crow AR; Siragam V; Freedman J; Lazarus AH
    Blood; 2005 Feb; 105(4):1546-8. PubMed ID: 15479722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia.
    Hansen RJ; Balthasar JP
    J Pharm Sci; 2003 Jun; 92(6):1206-15. PubMed ID: 12761810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
    Tremblay T; Paré I; Bazin R
    Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice.
    Won KD; Gil Gonzalez L; Cruz-Leal Y; Pavon Oro A; Lazarus AH
    J Immunol; 2024 May; 212(10):1531-1539. PubMed ID: 38506555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.
    Bazin R; Lemieux R; Tremblay T
    Br J Haematol; 2006 Oct; 135(1):97-100. PubMed ID: 16925577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.